Literature DB >> 19536601

Pancreatic cystic neoplasm: the role of cyst morphology, cyst fluid analysis, and expectant management.

Kevin K Leung1, William A Ross, Douglas Evans, Jason Fleming, E Lin, Eric P Tamm, Jeffrey H Lee.   

Abstract

BACKGROUND: Among pancreatic cysts, mucinous cystadenoma, and intraductal papillary mucinous neoplasms have the potential for malignant transformation. Differentiation between benign and potentially malignant/malignant (PMM) cysts remains difficult. The purpose of this study was to: (1) identify the diagnostic value of endoscopic ultrasound findings, serum, and cyst fluid tumor markers (CA19-9 and CEA), (2) determine the rate of subsequent surgical resection in patients initially managed conservatively, and (3) determine the role of cyst fluid viscosity "string sign" in differentiating pancreatic cysts.
METHODS: Patients with cytologic or pathologic diagnosis for pancreatic cystic neoplasms were analyzed.
RESULTS: The study included 79 patients. Cyst fluid CEA had a median of 1.0 ng/mL in benign cysts and 471.1 ng/mL in PMM cysts (P < .0001). Cyst fluid CA 19-9 was not statistically significant (P = .22). Neither serum CA 19-9 nor CEA was useful (P = .68 and P = .31). Increased cyst fluid viscosity was associated with PMM cysts (P < .0001). Median string sign was 0 mm in benign cysts and 3.5 mm in PMM cysts. The presence of thick walls (5 of 5, 100%) or intracystic growth (6 of 6, 100%) were associated with PMM cysts. Of the 50 patients with PMM cysts, 19 were treated conservatively. In those patients followed for more than 6 months, 2 of 12 (16.7%) had surgical resection after a median of 29.5 months for worrisome changes on imaging.
CONCLUSIONS: The presence of a thick cyst wall or intracystic growth, elevated cyst fluid CEA, and a long "string sign" were associated with PMM cysts. 16.7% of patients with a PMM cyst managed conservatively ultimately required surgical resection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19536601     DOI: 10.1245/s10434-009-0502-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  15 in total

1.  Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma.

Authors:  Ji Kon Ryu; Hanno Matthaei; Marco Dal Molin; Seung-Mo Hong; Marcia I Canto; Richard D Schulick; Christopher Wolfgang; Michael G Goggins; Ralph H Hruban; Leslie Cope; Anirban Maitra
Journal:  Pancreatology       Date:  2011-07-12       Impact factor: 3.996

Review 2.  Managing Incidental Pancreatic Cysts.

Authors:  Jennifer Phan; V Raman Muthusamy
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

3.  Utilization of ancillary studies in the cytologic diagnosis of biliary and pancreatic lesions: the Papanicolaou Society of Cytopathology guidelines for pancreatobiliary cytology.

Authors:  Lester J Layfield; Hormoz Ehya; Armando C Filie; Ralph H Hruban; Nirag Jhala; Loren Joseph; Philippe Vielh; Martha B Pitman
Journal:  Diagn Cytopathol       Date:  2014-04       Impact factor: 1.582

Review 4.  Controversies in the management of pancreatic IPMN.

Authors:  Masao Tanaka
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-01       Impact factor: 46.802

5.  Preoperative classification of pancreatic cystic neoplasms: the clinical significance of diagnostic inaccuracy.

Authors:  Clifford S Cho; Andrew J Russ; Agnes G Loeffler; Robert J Rettammel; Gregory Oudheusden; Emily R Winslow; Sharon M Weber
Journal:  Ann Surg Oncol       Date:  2013-04-18       Impact factor: 5.344

6.  Value of apparent diffusion coefficient for predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Lei Zhang; Sheng Xiang Rao; Xue Feng Xu; Dan Song Wang; Da Yong Jin; Meng Su Zeng
Journal:  Diagn Interv Radiol       Date:  2016 Jul-Aug       Impact factor: 2.630

Review 7.  Update on pancreatic cyst fluid analysis.

Authors:  Matthew Rockacy; Asif Khalid
Journal:  Ann Gastroenterol       Date:  2013

8.  Pancreatic cystic lesions: The value of contrast-enhanced endoscopic ultrasound to influence the clinical pathway.

Authors:  Michael Hocke; Xin-Wu Cui; Dirk Domagk; Andre Ignee; Christoph F Dietrich
Journal:  Endosc Ultrasound       Date:  2014-04       Impact factor: 5.628

9.  Pancreatic cyst fluid analysis for differential diagnosis between benign and malignant lesions.

Authors:  Renata Talar-Wojnarowska; Marek Pazurek; Lukasz Durko; Malgorzata Degowska; Grazyna Rydzewska; Jacek Smigielski; Adam Janiak; Marek Olakowski; Paweł Lampe; Piotr Grzelak; Ludomir Stefanczyk; Ewa Malecka-Panas
Journal:  Oncol Lett       Date:  2012-12-12       Impact factor: 2.967

Review 10.  Management of Incidental Pancreatic Cystic Lesions.

Authors:  Christian Jenssen; Stefan Kahl
Journal:  Viszeralmedizin       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.